**Dear editor**

We have read the article "Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women" by Fatani et al with great interest.[@b1-dmso-11-521]

As per National Cholesterol Education Program Adult Treatment Panel III guidelines, metabolic syndrome (MS) is diagnosed on the basis of the presence of three or more of the following five criteria: waist circumference (WC) over 40 inches (men) or 35 inches (women), fasting triglyceride (TG) level over 150 mg/ dL, blood pressure (BP) over 130/85 mmHg, fasting blood sugar over 100 mg/dL, and fasting high-density lipoprotein (HDL) cholesterol level \<40 mg/dL (men) or 50 mg/dL (women).[@b2-dmso-11-521]

Moreover, as per new JNC-8 guidelines, hypertension is defined as BP ≥140/90 mmHg, and in general, SBP value is more than DBP.[@b3-dmso-11-521] However, in the aforementioned article, SBP was presented as 70.19±3.66 in the control group and 106.62±5.67 in the MS group, and DBP was presented as 113.27±1.17 in the control group and 134.58±2.08 mmHg in the MS group. Specifically, increased DBP is secondary to another disorder of kidney or sleep apnea syndrome and thyroid.[@b4-dmso-11-521]

We would be highly obliged for your kind consideration of the abovementioned clarification in your article to avoid discrepancy and highlight a clear idea of the relationship between testosterone, obesity, and WC in the prediction of MS.
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